Benefits and drawbacks of open partial horizontal laryngectomies, Part B: Intermediate and selected advanced stage laryngeal carcinoma
- PMID: 25866908
- DOI: 10.1002/hed.24064
Benefits and drawbacks of open partial horizontal laryngectomies, Part B: Intermediate and selected advanced stage laryngeal carcinoma
Abstract
Background: Cancer of the larynx in the intermediate/advanced stage still presents a major challenge in terms of controlling the disease and preserving the organ. Among therapeutic options, open partial horizontal laryngectomy is proposed as a function-sparing surgical technique.
Methods: We analyzed the clinical outcomes of 555 patients with laryngeal cancer staged pT3 to pT4a who underwent open partial horizontal laryngectomy.
Results: Five-year overall survival (OS), disease-free survival (DFS), locoregional control, local control, laryngectomy-free survival, and laryngeal function preservation rates were 84.6%, 84.2%, 86.3%, 90.6%, 93.3%, and 91.2%, respectively. DFS, locoregional control, and laryngeal function preservation rates were significantly affected by pT4a staging (68.1%, 71.7%, and 78.0%, respectively), whereas pN+ influenced only DFS (≤72.6%) and locoregional control (≤79.6%).
Conclusions: Open partial horizontal laryngectomy with a modular approach can be considered effective in terms of prognostic and functional results in intermediate-stage and selected advanced-stage laryngeal cancers, even with subglottic extension. © 2015 Wiley Periodicals, Inc. Head Neck 38: E649-E657, 2016.
Keywords: laryngeal cancer; laryngeal function-sparing protocol; open partial laryngectomy; supracricoid partial laryngectomy; supratracheal partial laryngectomy.
© 2015 Wiley Periodicals, Inc.
Similar articles
-
Benefits and drawbacks of open partial horizontal laryngectomies, Part A: Early- to intermediate-stage glottic carcinoma.Head Neck. 2016 Apr;38 Suppl 1:E333-40. doi: 10.1002/hed.23997. Epub 2015 Jun 16. Head Neck. 2016. PMID: 25581514
-
Supratracheal laryngectomy: current indications and contraindications.Acta Otorhinolaryngol Ital. 2015 Jun;35(3):146-56. Acta Otorhinolaryngol Ital. 2015. PMID: 26246658 Free PMC article.
-
Oncologic outcomes of supratracheal laryngectomy: Critical analysis.Head Neck. 2015 Oct;37(10):1417-24. doi: 10.1002/hed.23773. Epub 2014 Jul 19. Head Neck. 2015. PMID: 24839082
-
Supratracheal partial laryngectomy: indications, oncologic and functional results.Curr Opin Otolaryngol Head Neck Surg. 2017 Apr;25(2):127-132. doi: 10.1097/MOO.0000000000000344. Curr Opin Otolaryngol Head Neck Surg. 2017. PMID: 28169863 Review.
-
[The current role of partial surgery as a strategy for functional preservation in laryngeal carcinoma].Acta Otorrinolaringol Esp. 2011 May-Jun;62(3):231-8. doi: 10.1016/j.otorri.2010.06.002. Epub 2010 Aug 3. Acta Otorrinolaringol Esp. 2011. PMID: 20684940 Review. Spanish.
Cited by
-
Patterns of recurrence after open partial horizontal laryngectomy types II and III: univariate and logistic regression analysis of risk factors.Acta Otorhinolaryngol Ital. 2019 Aug;39(4):235-243. doi: 10.14639/0392-100X-2409. Acta Otorhinolaryngol Ital. 2019. PMID: 31501615 Free PMC article.
-
Arytenoid Fixation in Laryngeal Cancer: Radiological Pictures and Clinical Correlations with Respect to Conservative Treatments.Cancers (Basel). 2019 Mar 13;11(3):360. doi: 10.3390/cancers11030360. Cancers (Basel). 2019. PMID: 30871238 Free PMC article.
-
Comparison of Current Surgical and Non-Surgical Treatment Strategies for Early and Locally Advanced Stage Glottic Laryngeal Cancer and Their Outcome.Cancers (Basel). 2020 Mar 20;12(3):732. doi: 10.3390/cancers12030732. Cancers (Basel). 2020. PMID: 32244899 Free PMC article. Review.
-
Open partial horizontal laryngectomy for T2-T3-T4a laryngeal cancer: oncological outcomes and prognostic factors of two Italian hospitals.Eur Arch Otorhinolaryngol. 2022 Jun;279(6):2997-3004. doi: 10.1007/s00405-021-07238-x. Epub 2022 Jan 3. Eur Arch Otorhinolaryngol. 2022. PMID: 34978589
-
Current Status of Partial Laryngeal Surgery for Advanced Laryngeal Cancer: When and Why?Curr Oncol Rep. 2024 Jun;26(6):614-624. doi: 10.1007/s11912-024-01516-7. Epub 2024 Apr 22. Curr Oncol Rep. 2024. PMID: 38647994 Free PMC article. Review.